Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P71
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 13.54% |
| Q3 2025 | 14.29% |
| Q2 2025 | -117.15% |
| Q1 2025 | 454.77% |
| Q4 2024 | -32.96% |
| Q3 2024 | 23.11% |
| Q2 2024 | 30.53% |
| Q1 2024 | -51.90% |
| Q4 2023 | 24.00% |
| Q3 2023 | -27.80% |
| Q2 2023 | 28.27% |
| Q1 2023 | 8.70% |
| Q4 2022 | -33.16% |
| Q3 2022 | 8.81% |
| Q2 2022 | 36.83% |
| Q1 2022 | -18.94% |
| Q4 2021 | 9.20% |
| Q3 2021 | -5.23% |
| Q2 2021 | -2.90% |
| Q1 2021 | -55.03% |
| Q4 2020 | -37.33% |
| Q3 2020 | 15.34% |
| Q2 2020 | -19.86% |
| Q1 2020 | -50.70% |
| Q4 2019 | -42.12% |
| Q3 2019 | -5.70% |
| Q2 2019 | 27.30% |
| Q1 2019 | -188.51% |
| Q4 2018 | -28.45% |
| Q3 2018 | 11.91% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |